Finance

Beta
Lists
50BA:FRA
Bicycle Therapeutics PLC
€3.56
-1.11%
(-0.040) 1D
Jun 4, 8:04:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 50BA...
Open
€3.44
High
€3.56
Low
€3.44
Mkt. cap
298.09M
Avg. vol.
26.00
Volume
0.00
52-wk high
€7.80
52-wk low
€3.44
No. of employees
288
Open
€3.44
High
€3.56
Low
€3.44
Mkt. cap
298.09M
Avg. vol.
26.00
Volume
0.00
52-wk high
€7.80
52-wk low
€3.44
No. of employees
288
News stories
From sources across the web
About Bicycle Therapeutics PLC
CEOKevin Lee
Employees288
Founded2009
Headquarters-
SectorBiotechnology
Websitebicycletherapeutics.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
2.92M
11.73M
47.96M
887.00K
Cost of goods sold
71.03M
56.61M
45.92M
46.96M
Cost of revenue
71.03M
56.61M
45.92M
46.96M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
18.49M
20.67M
22.55M
19.41M
Operating expense
18.49M
20.67M
22.55M
19.41M
Total operating expenses
89.52M
77.28M
68.46M
66.37M
Operating income
-86.60M
-65.55M
-20.51M
-65.48M
Other non operating income
-
-
-
-
EBT including unusual items
-79.18M
-58.90M
-18.89M
-60.65M
EBT excluding unusual items
-79.18M
-58.90M
-14.69M
-60.65M
Income tax expense
-231.00K
205.00K
1.26M
172.00K
Effective tax rate
0.29%
-0.35%
-6.70%
-0.28%
Other operating expenses
-
-
-
-
Net income
-78.95M
-59.10M
-20.15M
-60.82M
Net profit margin
-2,703.84%
-503.66%
-42.03%
-6,857.38%
Earnings per share
-1.14
-0.85
-0.29
-0.87
Interest and investment income
7.47M
6.70M
5.88M
4.88M
Interest expense
-54.00K
-44.00K
-57.00K
-48.00K
Net interest expenses
7.42M
6.66M
5.82M
4.83M
Depreciation and amortization charges
-
-
-
-
EBITDA
-84.91M
-63.80M
-19.17M
-64.35M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer